Medicare Panel Backs Coverage For Provenge Vaccine

A closely watched meeting ended with….not much of a surprise. An advisory panel to the Centers for Medicare Medicaid Services voted that Dendreon's Provenge vaccine for advanced prostate cancer shows “clinically significant” improvement ...